Synvivia, Inc.

Biotechnology company · Berkeley, California, United States

Synvivia, Inc. is a biotechnology company headquartered in Berkeley, California, United States. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $1.9 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $54,096 sold in a notice filed in 2023.

www.synvivia.comProfile compiled from public records. Is this your company? Request a correction or update

Synvivia at a glance

Typebiotechnology company
HeadquartersBerkeley, California, United States
Employees (self-reported, 2025)3
SEC CIK2003070

What does Synvivia do?

US government research funding

2 SBIR/STTR small-business research awards from US health agencies, $1.9 million in total (2016 to 2025). NIH funding came from the National Institute of General Medical Sciences, National Institute of Diabetes and Digestive and Kidney Diseases.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $54,096 sold (2023).

Frequently asked questions about Synvivia

Where is Synvivia headquartered?

Synvivia, Inc. is headquartered in Berkeley, California, United States.

What does Synvivia do?

Synvivia, Inc. is a biotechnology company.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences